vs
Side-by-side financial comparison of Inogen Inc (INGN) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $50.3M, roughly 1.4× READING INTERNATIONAL INC). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-1.9M). Over the past eight quarters, READING INTERNATIONAL INC's revenue compounded faster (5.6% CAGR vs 4.2%).
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
INGN vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $68.6M | $50.3M |
| Net Profit | — | $-2.6M |
| Gross Margin | 51.4% | — |
| Operating Margin | -13.6% | -1.9% |
| Net Margin | — | -5.1% |
| Revenue YoY | 3.4% | -14.2% |
| Net Profit YoY | — | -14.5% |
| EPS (diluted) | $-0.26 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.6M | $50.3M | ||
| Q3 25 | $79.1M | $52.2M | ||
| Q2 25 | $79.2M | $60.4M | ||
| Q1 25 | $68.5M | $40.2M | ||
| Q4 24 | $66.3M | $58.6M | ||
| Q3 24 | $74.9M | $60.1M | ||
| Q2 24 | $74.4M | $46.8M | ||
| Q1 24 | $63.1M | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-5.3M | $-4.2M | ||
| Q2 25 | $-4.2M | $-2.7M | ||
| Q1 25 | $-6.2M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-6.0M | $-7.0M | ||
| Q2 24 | $-5.6M | $-12.8M | ||
| Q1 24 | $-14.6M | $-13.2M |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | 53.1% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 55.2% | — | ||
| Q2 24 | 57.4% | — | ||
| Q1 24 | 54.5% | — |
| Q4 25 | -13.6% | -1.9% | ||
| Q3 25 | -9.0% | -0.6% | ||
| Q2 25 | -7.7% | 4.8% | ||
| Q1 25 | -11.2% | -17.2% | ||
| Q4 24 | -17.2% | 2.6% | ||
| Q3 24 | -10.4% | -0.6% | ||
| Q2 24 | -9.5% | -16.4% | ||
| Q1 24 | -25.8% | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | -6.7% | -8.0% | ||
| Q2 25 | -5.2% | -4.4% | ||
| Q1 25 | -9.0% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -8.0% | -11.7% | ||
| Q2 24 | -7.5% | -27.4% | ||
| Q1 24 | -23.1% | -29.4% |
| Q4 25 | $-0.26 | $-0.11 | ||
| Q3 25 | $-0.20 | $-0.18 | ||
| Q2 25 | $-0.15 | $-0.12 | ||
| Q1 25 | $-0.25 | $-0.21 | ||
| Q4 24 | $-0.41 | $-0.11 | ||
| Q3 24 | $-0.25 | $-0.31 | ||
| Q2 24 | $-0.24 | $-0.57 | ||
| Q1 24 | $-0.62 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.7M | $10.5M |
| Total DebtLower is stronger | — | $185.1M |
| Stockholders' EquityBook value | $192.2M | $-18.2M |
| Total Assets | $298.6M | $434.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.7M | $10.5M | ||
| Q3 25 | $106.5M | $8.1M | ||
| Q2 25 | $103.7M | $9.1M | ||
| Q1 25 | $118.9M | $5.9M | ||
| Q4 24 | $113.8M | $12.4M | ||
| Q3 24 | $105.7M | $10.1M | ||
| Q2 24 | $97.9M | $9.3M | ||
| Q1 24 | $107.4M | $7.5M |
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $192.2M | $-18.2M | ||
| Q3 25 | $197.2M | $-12.1M | ||
| Q2 25 | $199.5M | $-7.7M | ||
| Q1 25 | $198.0M | $-8.1M | ||
| Q4 24 | $173.9M | $-4.4M | ||
| Q3 24 | $185.4M | $1.6M | ||
| Q2 24 | $187.6M | $6.5M | ||
| Q1 24 | $191.9M | $18.0M |
| Q4 25 | $298.6M | $434.9M | ||
| Q3 25 | $307.0M | $435.2M | ||
| Q2 25 | $312.0M | $438.1M | ||
| Q1 25 | $308.4M | $441.0M | ||
| Q4 24 | $296.2M | $471.0M | ||
| Q3 24 | $306.2M | $495.7M | ||
| Q2 24 | $308.9M | $494.9M | ||
| Q1 24 | $315.6M | $494.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-943.0K | $4.3M |
| Free Cash FlowOCF − Capex | $-1.9M | $4.1M |
| FCF MarginFCF / Revenue | -2.8% | 8.2% |
| Capex IntensityCapex / Revenue | 1.4% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.7M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-943.0K | $4.3M | ||
| Q3 25 | $2.2M | $295.0K | ||
| Q2 25 | $4.3M | $1.6M | ||
| Q1 25 | $-16.8M | $-7.7M | ||
| Q4 24 | $-3.0M | $8.0M | ||
| Q3 24 | $7.0M | $1.3M | ||
| Q2 24 | $6.7M | $-10.4M | ||
| Q1 24 | $-4.7M | $-2.8M |
| Q4 25 | $-1.9M | $4.1M | ||
| Q3 25 | $1.6M | $-246.0K | ||
| Q2 25 | $3.7M | $1.2M | ||
| Q1 25 | $-17.1M | $-8.0M | ||
| Q4 24 | $-3.3M | $7.0M | ||
| Q3 24 | $5.3M | $-1.1M | ||
| Q2 24 | $6.6M | $-10.6M | ||
| Q1 24 | $-6.1M | $-4.7M |
| Q4 25 | -2.8% | 8.2% | ||
| Q3 25 | 2.0% | -0.5% | ||
| Q2 25 | 4.6% | 1.9% | ||
| Q1 25 | -24.9% | -19.8% | ||
| Q4 24 | -5.0% | 12.0% | ||
| Q3 24 | 7.1% | -1.8% | ||
| Q2 24 | 8.9% | -22.7% | ||
| Q1 24 | -9.6% | -10.4% |
| Q4 25 | 1.4% | 0.3% | ||
| Q3 25 | 0.7% | 1.0% | ||
| Q2 25 | 0.9% | 0.6% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.5% | 1.7% | ||
| Q3 24 | 2.2% | 4.0% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 2.1% | 4.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
